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Abstract
Caralluma flava (N.E.Br.) is a medicinal plant which is gaining renowned attention in scientific community due to its potential
curative powers. Traditionally, it is used in Arab regions as an anti-diabetic and anti-ulcer. It is also used as an anti-inflammatory,
anti-parasitic and anti-pyretic. Due to its pharmacological values, initial biological activities of C. flava have been carried out
recently and some pregnane glycoside molecules have been isolated and identified from its sap. The plant lacks the reports
of phytochemical studies and pharmacological activities which support its further investigation and validation of the traditional
therapeutic claims. The compiled data in this review is intended to serve as a reference to many researchers and may help them
to focus on the priority areas of research yet to be discovered.
Keywords: Caralluma flava; pregnane glycoside; anticancer activity; Desmidorchis flava
Introduction
Caralluma flava (N.E.Br.) Meve & Liede is a succulent herb
which grows wildly in many regions of Sultanate of Oman,
Yemen and United Arab Emirates [1-5]. It burgeons after rain
and mainly found on stony sides of the wadies, dry riverbeds,
and hillsides. The fresh juicy stems of this cactus-like plant are
collected by the natives and consumed as food. Due to its ex-
tremely bitter taste, it is eaten with an addition of spices and
lemon. It has bright yellow flowers which are quite unmistakable
to identify and are also edible. These flowers have an unpleasant
odor and a distinctive flavor with a sweet aftertaste [6-8]. The
plant is available in the vegetable and local markets of Arab re-
gions in fresh and dried powdered forms. It is very well known
for its medicinal properties [9]. Taxonomical classification of C.
flava is given in Table-1.
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Table 1 Taxonomic Classification of C. flava
Kingdom : Plantae
Phylum : Magnoliophyta
Class : Magnoliopsida
Order : Gentianales
Family : Apocynaceae
genus : Caralluma
specie : flava
Plant’s Name : Caralluma flava (N.E.Br.) Meve & Liede
Synonyms : Desmidorchis flava (N.E.Br.) Meve & Liede
: Crenulluma flava (N.E.Br.) Plowes
: Desmidorchis flavus
Vernacular
names
: Zoja (Jibbali Arabic)
: Duru-el-kebeh (Dhofari Arabic)
Botanical description
C. flava is a succulent stemmed herb forming clumps up to 30
cm high and 50 cm across. The stems are greyish-green often
red-tinged, erect, branched and 4-angled with prominent white
callus scars frequent on the stem edges. Young stems are cov-
ered with disk-shaped trichomes and more or less grow straight.
Inflorescences are umbellate with 15-30 flowers [2,10]. Its pedi-
cles are slender and 1-2 cm long. The flowers are yellow in color,
all about 0.8-1.0 cm in diameter. The calyxes are five-lobed and
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each lobe is 2-3 mm long and free almost to base. Its bright yel-
low to greenish yellow corollas are shortly cup-shaped below
with 5 spreading narrowly triangular lobes. It has pale yellow
coronas which are 1-2 mm across. Fruits are straight, narrow
cylindrical bladders up to 10 cm long. Seeds are brown with a
tuft of long white hairs at the tip [10-13].
Traditional Uses
The plant of C. flava is traditionally used in Arabian medicine to
treat peptic ulcer and diabetes. It is consumed freshly by many
people in the treatment of leprosy, gastric ulcer, rheumatism and
as antipyretic. Drops of its juice are used for ear inflammation
[13-15]. The sap inside its stems is externally applied to cuts and
wounds to speed convalescence. The succulent stems are rubbed
on burns to soothe them and used as a cooling agent on sunburns
and itchy-skin. Fresh stems are eaten raw with an addition of
lemon and salt for constipation. Tea prepared from the powdered
of dried plant is taken for liver disorders, gas trouble, high blood
pressure and diabetes. It is also used by the natives to suppress
hunger and quench thirst [16-18].
Phytochemical studies
The phytochemistry of several species of Caralluma is reported
with pregnane and its glycosides [19]. In common with other
Caralluma species, many pregnane glycoside molecules are
identified from this species. In 2015, Raees et al. and his cowork-
ers published the first phytochemical report on C. flava in which
two new pregnane glycosides, namely desmiflavasides A (1) and
B (2) (Figure 2), were isolated from the plant sap [20]. Later on,
the same group reported seven more new pregnane glycosides
viz., desmiflavasides C (3) and D (4), nizwaside (5) and desflava-
sides A-D (6-9) from the same source [21-23]. Glucose, digi-
talose, cymarose, allomerose and thevetose sugar units were de-
tected in these molecules. Compounds 3-8 had a pair of benzoyl
groups attached to the aglycon portion. The structural characteri-
zation of all the isolates was achieved by using different multidi-
mensional NMR techniques. 1D-TOCSY experiments were per-
formed to determine the correlations between all protons within
each sugar units. So far, no phytochemical constituent has been
reported from the crude extract of the plant.
Pharmacological studies
Anti-proliferative activity
Anti-proliferative effects of isolated chemical constituents from
the sap of C. flava were studied using MTT assays and re-
sults confirmed their worth in the treatment of cancer [20-
22]. Compounds 3 and 4 showed concentration-dependent anti-
proliferative effects on MDA-MB231 breast cancer cells and
demonstrated significant growth inhibition of the malignant
cells, after 24 hours, with apparent IC50 values of 19.97 µM
and 25.84 µM, respectively. Compound 5 possessed strong anti-
proliferative activity (IC50:23.5 µg/ml) on the same cancer cell
line and was found to be more active than the standard doxoru-
bicin. Treatment of normal breast epithelium cells (MCF10-2A)
with these compounds (3-5) demonstrated no remarkable growth
inhibition and indicated selective cytotoxicity towards the cancer
cells only [21-22].
Anti-ulcer activity
In 2017, Al-Naqeb published the first report on the anti-
ulcerative potential of the methanolic extract of C. flava against
ethanol-induced gastric ulcer in rats model. The results showed
significant anti-ulcerative effect comparable to omeprazole used
as a standard. The extract reduced the incidence and severity
of ulceration by 68.39% protection at a dose of 500mg/kg.
Whereas, omeprazole exhibited 47.11% of inhibition at a dose
of 20mg/kg. In PH examination, the treated rats with C. flava
methanolic extract (3.74±0.42) showed significant less acidity
as compared to the control rats (1.56±0.04) which revealed its
protective behavior against gastric ulcer [14].
Anti-hyperglycemic activity
C. flava is reported to possess hypoglycemic activity. Its aqueous
extract showed significant effects in adjusting the raised blood
glucose level in streptozotocin-induced diabetic rats. After 28
days of extract administration, the blood glucose level was low-
ered from 14.23 mg/100 ml to 8.45 mg/100 ml at a dose of
0.5g/kg [15].
Acute toxicity
Although, C. flava is consumed freshly by many people in
Oman, Yemen, and the United Arab Emirates as a traditional but
no scientific research was performed until recently to evaluate
the toxicity of the plant. In 2017, Al-Naqeb evaluated the safety
profile of C. flava plant for the very first time by treating rats
with a single dose of its methanolic extract (3 g/kg) for 14 days.
The results showed no significant toxicological symptoms and
signs of abnormalities such as behavioral changes and alteration
in body weight [14].
Antioxidant activity
According to a study undertaken by Karthishwaran et al., C.
flava possesses strong antioxidant activity. The antioxidant po-
tential of its ethanolic extract was evaluated in-vitro by us-
ing 2, 2’-diphenyl-1-picrylhydrazyl (DPPH), 2,2-azino-bis-3-
ethylbenzothiazoline-6-sulfonic acid (ABTS), nitric oxide radi-
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Figure 1 Caralluma flava N.E.Br. Meve & Liede (Snapshot was taken inthe mountains of Jebel Akhdar in Sultanate of Oman by Rashid Al-Harrasi;
11hr 45min/16 April 2016)
Figure 2 Structures of pregnane glycosides (1-9) isolated from C. flava
cal and hydroxyl radical scavenging assays [24]. The methanolic
extract of the plant also reduced DPPH radical very strongly and
the results were similar to the standard L-ascorbic acid [14].
Conclusion
The review of literature signifies the medicinal importance of C.
flava which is being used as an antidiabetic and antiulcer in the
Arab traditional medicine. The phytoconstituents present in the
plant are mainly pregnane glycosides which can be attributed
to its medicinal actions. Further pharmacological studies of C.
flava crude extract and its active compounds need to be car-
ried out in order to confirm its medicinal potentials and also to
discover its other pharmacological actions. Less information is
available regarding the chemical constituents of the plant. So,
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there is a good scope to isolate and identify new compounds
from C. flava considering its wide pharmacological profile.
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